For the Inventor, By the Inventor

Enter assignee name

Montreal, Canada

Thallion Pharmaceuticals Inc.

USPTO Granted Patents = 14

% Expired Patents = 92.9

EPO Patents = 1

Forward Citations = 28

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Emmanuel Zazopoulos (8 out of 14 patents)

Chris M Farnet (8 out of 17 patents)

James B McAlpine (7 out of 10 patents)

4. Arjun H Banskota (4 out of 4 patents)

5. Alfredo Staffa (3 out of 8 patents)

6. Mustapha Aouidate (3 out of 3 patents)

7. Brian O Bachmann (2 out of 7 patents)

8. François Berger (2 out of 10 patents)

9. Mahmood Piraee (2 out of 4 patents)

10. Faustinus Yeboah (2 out of 2 patents)

11. Henriette Gourdeau (2 out of 5 patents)

12. Maxime Ranger (2 out of 7 patents)

13. Pierre Falardeau (1 out of 3 patents)

14. Bryan Simard (1 out of 1 patent)

15. Ashraf Ibrahim (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 8361759 - Process for producing farnesylated dibenzodiazepinone by fermentation (2013-01-29),

2. 8076287 - Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals (2011-12-13),

3. 7763604 - Methods for administration of a farnesyl dibenzodiazepinone (2010-07-27),

4. 7655646 - Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals (2010-02-02),

5. 7635765 - Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin (2009-12-22),

6. 7521222 - Farnesyl dibenzodiazepinone and processes for its production (2009-04-21),

7. 7462705 - Nucleic acids encoding an enediyne polyketide synthase complex (2008-12-09),

8. 7416868 - Polyene polyketides, processes for their production and their use as a pharmaceutical (2008-08-26),

9. 7384935 - Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals (2008-06-10),

10. 7375088 - Polyene polyketides, processes for their production and their use as a pharmaceutical (2008-05-20),

11. 7358241 - Compositions and methods comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions (2008-04-15),

12. 7312339 - Polyene oxazoles and processes for their preparation (2007-12-25),

13. 7304054 - Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals (2007-12-04),

14. 7257562 - High throughput method for discovery of gene clusters (2007-08-14),

Company Overview

Thallion Pharmaceuticals Inc. is a biopharmaceutical company based in Montreal, Canada, focused on developing innovative therapies for infectious diseases and cancer. The organization specializes in the research and development of novel drug candidates, leveraging advanced technologies to address unmet medical needs. Thallion's commitment to scientific excellence drives its efforts in creating effective treatments that enhance patient outcomes, positioning the company as a key player in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#69 in Montreal

#1,067 in Canada

#42,249 in the World

Montreal, Canada

Thallion Pharmaceuticals Inc.

Forward Citations = 28

18 inventors:

Emmanuel Zazopoulos (8 out of 14 patents)

Chris M Farnet (8 out of 17 patents)

James B McAlpine (7 out of 10 patents)

4. Arjun H Banskota (4 out of 4 patents)

5. Alfredo Staffa (3 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Thallion Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/thallion-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…